US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

IMUX

Immunic (IMUX)

Immunic Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMUX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/13	22 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2025/01/07	20 : 30	PR Newswire (US)	Immunic Highlights 2024 Accomplishments and Upcoming Milestones	NASDAQ:IMUX	Immunic Inc
2024/12/19	06 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/12/09	22 : 30	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/12/07	07 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/12/07	07 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/12/07	07 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/12/07	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/12/07	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/11/26	20 : 30	PR Newswire (US)	Immunic, Inc. to Participate in Investor Conference in December	NASDAQ:IMUX	Immunic Inc
2024/11/15	07 : 33	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/11/14	20 : 58	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:IMUX	Immunic Inc
2024/11/14	04 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMUX	Immunic Inc
2024/11/13	20 : 30	PR Newswire (US)	Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology	NASDAQ:IMUX	Immunic Inc
2024/11/12	23 : 31	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:IMUX	Immunic Inc
2024/11/07	21 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMUX	Immunic Inc
2024/11/07	20 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/11/07	20 : 30	PR Newswire (US)	Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/10/31	19 : 30	PR Newswire (US)	Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update	NASDAQ:IMUX	Immunic Inc
2024/10/29	19 : 30	PR Newswire (US)	Immunic to Participate in Industry, Scientific and Investor Conferences in November	NASDAQ:IMUX	Immunic Inc
2024/10/22	19 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/10/22	19 : 30	PR Newswire (US)	Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis	NASDAQ:IMUX	Immunic Inc
2024/09/18	19 : 30	PR Newswire (US)	Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis	NASDAQ:IMUX	Immunic Inc
2024/09/11	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/09/04	19 : 30	PR Newswire (US)	Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome	NASDAQ:IMUX	Immunic Inc
2024/09/03	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/08/28	19 : 30	PR Newswire (US)	Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September	NASDAQ:IMUX	Immunic Inc
2024/08/08	20 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMUX	Immunic Inc
2024/08/08	19 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMUX	Immunic Inc
2024/08/08	19 : 30	PR Newswire (US)	Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:IMUX	Immunic Inc

Showing the most relevant articles for your search:NASDAQ:IMUX

1 2 3 4 5 6 7 8 9 10 次へ >>

Bank of America

US Dollar vs Yen

BNP Paribas (QX)

US Dollar vs Sterling

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約